These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 12642359

  • 1. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.
    Geier C, Perrot A, Ozcelik C, Binner P, Counsell D, Hoffmann K, Pilz B, Martiniak Y, Gehmlich K, van der Ven PF, Fürst DO, Vornwald A, von Hodenberg E, Nürnberg P, Scheffold T, Dietz R, Osterziel KJ.
    Circulation; 2003 Mar 18; 107(10):1390-5. PubMed ID: 12642359
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ.
    Mol Genet Metab; 2006 May 18; 88(1):78-85. PubMed ID: 16352453
    [Abstract] [Full Text] [Related]

  • 4. Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and alpha-actinin and their implication for hypertrophic cardiomyopathy.
    Gehmlich K, Geier C, Osterziel KJ, Van der Ven PF, Fürst DO.
    Cell Tissue Res; 2004 Aug 18; 317(2):129-36. PubMed ID: 15205937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
    Geier C, Gehmlich K, Ehler E, Hassfeld S, Perrot A, Hayess K, Cardim N, Wenzel K, Erdmann B, Krackhardt F, Posch MG, Osterziel KJ, Bublak A, Nägele H, Scheffold T, Dietz R, Chien KR, Spuler S, Fürst DO, Nürnberg P, Ozcelik C.
    Hum Mol Genet; 2008 Sep 15; 17(18):2753-65. PubMed ID: 18505755
    [Abstract] [Full Text] [Related]

  • 7. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
    Konno T, Shimizu M, Ino H, Matsuyama T, Yamaguchi M, Terai H, Hayashi K, Mabuchi T, Kiyama M, Sakata K, Hayashi T, Inoue M, Kaneda T, Mabuchi H.
    J Am Coll Cardiol; 2003 Mar 05; 41(5):781-6. PubMed ID: 12628722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L, Pieroni M, Chimenti C, Simionati B, Zimbello R, Maseri A, Frustaci A, Lanfranchi G.
    Biochem Biophys Res Commun; 2003 Sep 19; 309(2):391-8. PubMed ID: 12951062
    [Abstract] [Full Text] [Related]

  • 12. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.
    Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L.
    J Mol Cell Cardiol; 2000 Sep 19; 32(9):1687-94. PubMed ID: 10966831
    [Abstract] [Full Text] [Related]

  • 13. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, Bristow MR, Mestroni L.
    Circulation; 2005 Jul 05; 112(1):54-9. PubMed ID: 15998695
    [Abstract] [Full Text] [Related]

  • 14. Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.
    Riaz M, Park J, Sewanan LR, Ren Y, Schwan J, Das SK, Pomianowski PT, Huang Y, Ellis MW, Luo J, Liu J, Song L, Chen IP, Qiu C, Yazawa M, Tellides G, Hwa J, Young LH, Yang L, Marboe CC, Jacoby DL, Campbell SG, Qyang Y.
    Circulation; 2022 Apr 19; 145(16):1238-1253. PubMed ID: 35384713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A, Tebo M, Ingles J, Nguyen L, Tsoutsman T, Lam L, Chiu C, Chung J, Weintraub RG, Semsarian C.
    J Mol Cell Cardiol; 2005 Feb 19; 38(2):387-93. PubMed ID: 15698845
    [Abstract] [Full Text] [Related]

  • 17. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.
    Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ.
    Circ Res; 2007 Mar 30; 100(6):766-8. PubMed ID: 17347475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
    Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, Müller OJ, McGrath MJ, Vollert I, Hansen A, Linke WA, Hengstenberg C, Bonne G, Morner S, Wichter T, Madeira H, Arbustini E, Eschenhagen T, Mitchell CA, Isnard R, Carrier L.
    Hum Mol Genet; 2012 Jul 15; 21(14):3237-54. PubMed ID: 22523091
    [Abstract] [Full Text] [Related]

  • 20. Titin mutations as the molecular basis for dilated cardiomyopathy.
    Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, Takahashi M, Hohda S, Ueda K, Nouchi T, Hiroe M, Marumo F, Imaizumi T, Yasunami M, Kimura A.
    Biochem Biophys Res Commun; 2002 Feb 22; 291(2):385-93. PubMed ID: 11846417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.